Trials / Completed
CompletedNCT03714295
Impact of Interdental Brushing on the Evolution of Supra-gingival Bacterial Flora (BACTERIB)
Impact of Interdental Brushing on the Evolution of Supra-gingival Bacterial Flora in Healthy Subjects Aged 18 to 35 Years (BACTERIB)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Claude Bernard University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
In France, two-thirds of adults over 35 years of age have at least a periodontal disease. The etiology is the accumulation of dental plaque, especially in interdental spaces. The cleaning of interdental spaces is particularly complex. This accumulation of dental plaque is at the origin of a modification of the bacterial flora in favor of periodontopathogenic bacteria. These pathogens can induce within the periodontal tissues an immune and inflammatory reaction that cause tissue degradation. The majority of studies focus on people over 30 years of age with gingivitis or periodontitis. However, young adults, in whom the initial or even reversible stages of periodontal disease are the most frequent, should be the preferred target of preventive measures for this pathology. The main objective of this study is to quantify, in healthy patients, the evolution of the supragingival bacterial flora, in the interdental spaces, following the daily passage of brushes with the adapted diameter and single passage. The secondary objective is to evaluate the qualitative change in the bacterial flora (proportions of periodontal bacteria / commensal bacteria) following the interdental cleaning.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Use of interdental brushes | No intervention they just use interdental brushes as it should be done routinely |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-04-15
- Completion
- 2015-07-01
- First posted
- 2018-10-22
- Last updated
- 2018-10-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03714295. Inclusion in this directory is not an endorsement.